Mon, Jul
42 New Articles

Nove and PwC Advise on Sale of Mercurio to OneMed

Nove and PwC Advise on Sale of Mercurio to OneMed

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Nove has advised Futurma OU on its sale of 100% shareholding in Mercurio OU to OneMed OU in Estonia. PwC Legal advised OneMed on the acquisition.

Since 2011 Mercurio has been operating in the Baltics mainly as a distributor of ResMed sleep apnea equipment and accessories. The company manages medical data systems and the medical devices web store Meditsiiniseadmed.ee. Mercurio is a Baltic partner to Nox Medical, a developer and manufacturer of respiratory diagnosis devices, and to Nonin, a developer and manufacturer of pulse oximetry equipment.

OneMed is a medical products distributor that is headquartered in Sweden with offices in 12 countries. The Estonian office of OneMed started its operations in 1993.

The Nove team consisted of Partner Urmas Volens and Lawyer Triin Tiru.

The PwC team was led by Attorney-at-Law Indrek Ergma and included Senior Associates Imbi Jurgen and Karin Marosov and Associates Maris Alt and Erik Salur.